Rising population cost for treating people living with HIV in the UK, 1997-2013

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Mandalia, Sundhiya ^a,b,c   Mandalia, Roshni ^a   Lo, Gary ^a,c   Chadborn, Tim ^d   Sharott, Peter ^e   Youle, Mike ^a,f   Anderson, Jane ^g   Baily, Guy ^h   Brettle, Ray ⁱ   Fisher, Martin ^j   Gompels, Mark ^k   Kinghorn, George ^l   Johnson, Margaret ^f   McCarron, Brendan ^m   Pozniak, Anton ^c   Tang, Alan ⁿ   Walsh, John ^o   White, David ^p   Williams, Ian ^q   Gazzard, Brian ^a,b,c   Beck, Eduard J ^a,c,r   more..

^a NPMS HHC Coordinating and Analytic Centre   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e London Specialised Commissioning Group   (United Kingdom)

^f ROYAL FREE HOSPITAL   (United Kingdom)

^g HOMERTON UNIVERSITY HOSPITAL   (United Kingdom)

^h ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

ⁱ WESTERN GENERAL HOSPITAL   (United Kingdom)

^j ROYAL SUSSEX COUNTY HOSPITAL   (United Kingdom)

^k SOUTHMEAD HOSPITAL   (United Kingdom)

^l ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

^m JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

ⁿ ROYAL BERKSHIRE HOSPITAL   (United Kingdom)

^o ST MARY S HOSPITAL   (United Kingdom)

^p BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^q UNIVERSITY COLLEGE LONDON   (United Kingdom)

^r LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; COMMUNITY CARE; DRUG COST; FEMALE; HEALTH CARE COST; HEALTH CARE NEED; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HOSPITAL SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; SURVIVAL TIME; UNITED KINGDOM; ALGORITHM; COST; ECONOMICS; HEALTH ECONOMICS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; PROSPECTIVE STUDY; REGRESSION ANALYSIS; STATISTICAL MODEL;

ALGORITHMS; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COSTS AND COST ANALYSIS; ECONOMICS, MEDICAL; FEMALE; GREAT BRITAIN; HEALTH CARE COSTS; HIV INFECTIONS; HUMANS; MALE; MODELS, STATISTICAL; PROSPECTIVE STUDIES; REGRESSION ANALYSIS;

EID: 78651260635     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0015677     Document Type: Article

References (29)

1. European Centre for Disease Prevention and Control/WHO Regional Office for Europe (2009) HIV/AIDS surveillance in Europe 2008. Stockholm: European Centre for Disease Prevention and Control. 24-25. Available:http://www.euro.who.int/document/e93034.pdf Accessed November 2010.
2. Beck EJ, Mandalia S, Youle M, Brettle R, Fisher M, et al. (2008) Treatment Outcome and Cost-effectiveness of different HAART Regimens in the UK 1996-2002. International Journal of STD & AIDS 19: 297-304.
3. Health Protection Agency (2009) HIV in the United Kingdom: 2009 Report, London UK. Available: http://www.hpa.org.uk/web/HPAweb&HPAwebStandard/HPAweb_C/1259151891866. Accessed November 2010.
4. Health Protection Agency: Survey of Prevalent HIV Infections Diagnosed (SOPHID): Data tables 2008, London UK, 2009.
5. Beck EJ, Mandalia S (2003) The Cost of HIV Treatment and Care in England since HAART: Part 1. British Journal of Sexual Medicine 27(1): 19-21.
6. Beck EJ, Mandalia S (2003) The Cost of HIV Treatment and Care in England since HAART: Part 2. British Journal of Sexual Medicine 27(2): 21-23.
7. Beck EJ, Mandalia S, Gaudreault M, Brewer C, Zowall H, et al. (2004) The Cost-effectiveness of HAART, Canada 1991-2001. AIDS 18: 2411-9.
8. Badri M, Maartens G, Mandalia S, Bekker L-G, Penrod JR, et al. (2006) Costeffectiveness of Highly Active Antiretroviral Therapy in South Africa. Plos Medicine 3: e4.
9. Beck EJ, Mandalia S, Lo G, Youle M and Gazzard B for the NPMS-HHC Steering Group (2008) Use and Cost of HIV Service Provision in UK NPMSHHC Sites: aggregate analyses January 1996-2006. NPMS-HHC Coordinating and Analytic Centre, St. Stephen's Centre, Chelsea and Westminster Hospital Trust, London, UK.
10. Beck EJ, Miners AH (2001) Effectiveness and Efficiency in the Delivery of HIV Services: economic and related considerations in The Effective Management of HIV Disease, Gazzard B, Johnson M, Miles A, eds. London: Aesculapius Medical Press. pp 113-38.
11. Aldrich, John (2005) Fisher and Regression. Statistical Science 20(4): 401-417.
12. Health Protection Agency (2010) Survey of Prevalent HIV Infections Diagnosed (SOPHID): Data tables 2009, London UK. Available: http://www.hpa.org.uk/web/HPAwebFile/HPAweb_C/1221482342808. Accessed November 2010.
13. Beck EJ, Mandalia S, Lo Gary, Sharott P, Youle M, et al. (2010) PIboosted or NNRTI as first-line HAART regimens? Lessons from the UK. XVIII International AIDS Conference, Vienna, Austria: Abstract THPE0084.
14. Feature (2010) White paper: More brickbats than bouquets? BMJ;341:c3977. Available: http://www.bmj.com/cgi/content/full/341/jul28_2/c3977 Accessed November 2010.
15. WHO (2010) More than five million people receiving HIV treatment. Geneva, Available: http://www.who.int/mediacentre/news/releases/2010/hiv_treament_20100719/en/index.html Accessed November 2010.
16. Beck EJ, Walensky RP (2008) The Outcome and Impact of Ten Years of HAART, in: Zuniga JM, Whiteside A, Ghaziani A, Bartlett JG, eds. Oxford, UK: A Decade of HAART Oxford University Press. pp 45-62.
17. WHO (2010) Antiretroviral therapy for HIV infection in adults and adolescents, Recommendations for a public health approach, 2010 revision. Geneva, Available: http://whqlibdoc.who.int/publications/2010/9789241599764_eng.pdf. Accessed November 2010.
18. Severe P, Juste MAJ, Ambroise A, Eliacin L, Marchand C, et al. (2010) Early versus Standard Antiretroviral Therapy for HIV-Infected Adults in Haiti, New England Journal of Medicine 363: 257-65.
19. Loubiere S, Meiners C, Sloan C, Freedberg KA, Yazdanpanah Y (2010) Economic evaluation of ART in resource-limited countries. Curr Opin HIV AIDS 5: 225-31.
20. Hecht R, Bollinger L, John Stover J, William McGreevey W, Muhib F, et al. (2009) Critical Choices In Financing The Response To The Global HIV/AIDS Pandemic. Health Affairs 28: 1591-1605.
21. Hall HI, Green TA, Wolitski RJ, Holtgrave DR, Rhodes P, et al. (2010) Estimated Future HIV Prevalence, Incidence, and Potential Infections Averted in the United States: A Multiple Scenario Analysis. J Acquir Immune Defic Syndr 55: 271-6.
22. Montaner JSG, Lima VD, Barrios R, Yip B, Wood E, et al. (2010) Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study, Lancet. Available: http://press.thelancet.com/hivbc.pdf. Accessed November 2010.
23. Report of the Secretary-General (2010) Progress made in the implementation of the Declaration of Commitment on HIV/AIDS and the Political Declaration on HIV/AIDS. Sixty-fourth session of the General assembly, Agenda item 44, Implementation of the Declaration of Commitment on HIV/AIDS and the Political Declaration on HIV/AIDS, United Nations, New York, US.
24. Hankins CA, de Zalduondo BO (2010) Combination prevention: a deeper understanding of effective HIV prevention, AIDS, 24(suppl 4): S70-S80.
25. Kahn JG, Marseille E, Auvert B (2006) Cost-effectiveness of male circumcision for HIV prevention in a South African setting. PLoS Med 3(12): e517.
26. Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, et al. (2009) for the MOPH-TAVEG Investigators. Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand N Engl J Med 361: 1-12.
27. Baleta A (2010) Antiretroviral vaginal gel shows promise against HIV, Lancet. Available: http://download.thelancet.com/flatcontentassets/pdfs/S0140673610611233.pdf. Accessed November 2010.
28. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, et al. (2010) Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men NEJM. Available: http://www.nejm.org/doi/pdf/10.1056/NEJMoa1011205 Accessed November 2010 363: 1-13.
29. Poate D, Paul Balogun P, Attawell K (2009) UNAIDS Second Independent Evaluation 2002-2008, Final Report, ITAD and HLPS, UK. Available: http://data.unaids.org/pub/BaseDocument/2009/20091002_sie_final_report_en.pdf. Accessed November 2010.